CAS NO: | 1356447-90-9 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | GZ-793A is an orally active and selectivevesicular monoamine transporter-2 (VMAT2)inhibitor, with anKiof 0.029 μM. GZ-793A inhibits the neurochemical effects of methamphetamine (METH)-induced dopamine release. GZ-793A can be used for research of METH addiction[1][2][3]. | ||||||||||||||||
IC50& Target | Ki: 0.029 μM (VMAT2)[1]. | ||||||||||||||||
体内研究 (In Vivo) | GZ-793A (30, 60, 120 or 240 mg/kg; p.o.; once) decreases the number of METH infusions self-administered across each time interval evaluats in a dose-dependent manner[1].
| ||||||||||||||||
分子量 | 464.04 | ||||||||||||||||
Formula | C26H38ClNO4 | ||||||||||||||||
CAS 号 | 1356447-90-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |